Share
New psychedelic-assisted psychotherapy facility standards and call for assessors
Back to MessengerRead time: 1 minute
As we shared in January, an amendment to the Mental Health Services Protection Regulation introduced new requirements for psychedelic-assisted psychotherapy (PAPT), which went into effect on Jan. 16, 2023.
PAPT medical facilities
In response to these requirements, CPSA has launched new psychedelic-assisted psychotherapy accreditation standards. Our accreditation standards are based on input from field experts, best practices and research by other regulators, standard-setting bodies and industry associations. These standards make sure patients receive safe, high-quality care in accredited medical facilities.
As specified by the Mental Health Services Protection Regulation, PAPT provided in the community must be performed within a CPSA-accredited medical facility by a psychiatrist or a physician in consultation with a psychiatrist. Before facilities may provide this therapy, they must be assessed and accredited by CPSA. Once facilities have registered for assessment, they will be provided with a copy of the PAPT standards.
Help us accredit facilities: CPSA is now seeking PAPT assessors
Accreditation could not happen without contracted assessors. We’re currently looking for experts to help ensure patient safety in medical facilities across Alberta. If you are a registered nurse, registered psychiatric nurse or a licensed practical nurse with more than three years’ experience in treating post-traumatic stress disorder (PTSD), mood or related disorders, consider using your knowledge to earn continuing competence credits and compensation. If you know someone who fits this description, feel free to forward this opportunity along.
Learn more and apply to be a CPSA assessor.
Questions? Contact us at papt@cpsa.ab.ca.
Recent evidence shows that PAPT is an effective part of a comprehensive care plan for people with certain psychiatric disorders such as PTSD and treatment-resistant depression. Psychedelic drugs include psilocybin, psilocin, MDMA, LSD, mescalin (peyote), DMT, 5 methoxy DMT and ketamine. Patients who would benefit from PAPT will need a referral from their physician to gain access to this treatment. |
Related News
All News & EventsAugust 10, 2023
Continuing medical education and professional development opportunities – August 2023
August 10, 2023
Clarification: Virtual Care standard of practice
August 10, 2023
Are you up to standard? The importance of working together for patient safety
August 10, 2023
Comments for this post are now closed. If you would like to share your feedback on this topic, please email support@cpsa.ca.